Logo

Home

smallArrow

Stocks Screener

smallArrow

Syncom Formulations

Syncom Formulations Share Price

Syncom Formulations (INR)22.710.4   (1.9%)

Exchange ScripsBSE524470NSESYNCOMFISININE312C01025

Stock Performance
Fundamentals
Technicals
Shareholding Patterns
Financials
Similar Stocks

Trendline of performance -

Syncom Formulations Performance

Market performance
Open price22.39
High23.1
Volumes11535328
Prev Close22.71
Low21.75
Closing date2024-09-20
Historical performance
1 Year High27.90
3 Year High27.90
5 Year High27.90
1 Year Low7.25
3 Year Low4.60
5 Year Low4.60

Syncom Formulations Fundamentals

Company Valuation
Market Cap
Market Cap (₹Cr)
1194
Face Value
Face Value (₹)
1
P/E Ratio
P/E Ratio
106.37
Dividend Yield
Dividend Yield
N/A

Syncom Formulations Investment Returns

1 Year
164.1%
3 Years
N/A
5 Years
N/A
10 Years
N/A

Syncom Formulations Technicals

IndicatorsValueSignal
5-DMA23.39Bearish
10-DMA24.61Bearish
20-DMA22.82Bearish
50-DMA18.6Bullish
100-DMA15.72Bullish
200-DMA14.84Bullish

Shareholding Pattern

FieldJun-2024Mar-2024Dec-2023Sep-2023Jun-2023
Promoters1313131313
Foreign Investors---------------
Domestic Investors1313131313
Public Investors376517325748289969224239224912
Government---------------

Syncom Formulations Financials

Below figures are in Rs. Crores

ParticularsMar-2023Mar-2022Mar-2017Mar-2016
Other Income1461202827
Operating Profit345320193193
Interest341931
Depreciation45393130
Profit Before Tax266262159161
Consolidated Net Profit201198105104
Adjusted EPS------------

Balance Sheet

Below figures are in Rs. Crores

ParticularsMar-2023Mar-2022Mar-2017Mar-2016
Share Capital940862781781
Total Reserves16201309393306
Minority Interest------------
Total Non-Current Liabilities87787763
Total Liabilities3778308218391807
Capital Work in Progress25662247
Total Assets3778308218391807

Cash Flow

Below figures are in Rs. Crores

ParticularsMar-2023Mar-2022Mar-2017Mar-2016
Cash Flow from Operating Activities105163138241
Cash Flow from Investing Activities-450-271-177-227
Cash Flow from Financing Activitie3508347-24
Net Cash Inflow / Outflow6-248-11
0%
Negative
Neutral
Positive
  • The stock has a PE ratio of 106.37.
  • 3Y Stock Price CAGR of the stock is 180.4.
  • The stock has a beta of 0.8.
  • In the last financial year, the company had an EBITDA of ₹345 Million.
  • The company generated revenue of ₹2243 Million in the previous financial year.

Syncom Formulations

22.710.4   (1.9%)

Investment Amount: ₹ 850
Current Value: ₹ 2271
Performence: 167.2%
P/L: ₹ 1421
Top Gainers
SymbolChange%
ITDCEM562.45(19%)
MARKSANS318.35(16%)
CONCORDBIO2601.1(16%)
MAGADSUGAR957.45(14%)
PRSMJOHNSN219.54(12%)
Top Losers
SymbolChange%
ROSSELLIND170.85(-73%)
SADHNANIQ59.21(-9%)
BHARATRAS11914.5(-7%)
PEARLPOLY42.08(-7%)
SAKSOFT276.15(-7%)
AGIIL1042.6(-6%)
GATECH1.17(-6%)
XTGLOBAL41.63(-6%)
Similar stocks

Panacea Biotec

▲ 62.2

314.09

August 20 - September 20

Concord Biotech

▲ 57.1

2601.1

August 20 - September 20

Marksans Pharma

▲ 44.3

318.35

August 20 - September 20

Wanbury

▲ 38.6

278.79

August 20 - September 20

Jubilant Pharmova

▲ 34.5

1206.1

August 20 - September 20

Brooks Laboratories

▲ 33.6

147.47

August 20 - September 20

Nectar Lifesciences

▲ 29.9

42.25

August 20 - September 20

Biofil Chem & Pharma

▲ 29.7

83.6

August 20 - September 20

Announcing Stock of the Month!

 

Phone

Registered Users

10 lacs

Google Rating

4.6